Page 263 - The Vasculitides Volumes 2

Overview of the Treatment of Primary Systemic Vasculitis 239

[41] Israel, H. L. Sulfamethoxazole-trimethoprim therapy for Wegener?s granulomatosis.
Arch. Intern. Med. 1988; 148:2293-2295.

[42] Stegeman, C. A., Tervaert, J. W., Sluiter, W. J., et al. Association of chronic nasal
carriage of Staphylococcus aureus and high relapse rates in Wegener granulomatosis.
Ann. Intern. Med. 1994; 120:12-17.

[43] De Groot, K., Reinhold-Keller, E., Tatsis, E., et al. Therapy for maintenance of
remission in sixty-five patients with trimethoprim/sulfamethoxazole. Arthritis Rheum.
1996; 39:2052-2061.

[44] Meltzer, C., Hellmich, B., Gause, A., et al. Churg Strauss syndrome-successful
induction of remission with methotrexate and unexpected high cardiac and pulmonary
relapse ratio during maintenance treatment. Clin. Exp. Rheumatol. 2004; 22(Suppl. 36):
S52-S61.

[45] Clain, J. M., Specks, U. Rituximab for ANCA-associated vasculitis: the experiences in
the United States. Presse Med. 2013; 42:530-532.

[46] Kim, S., Marigowda, G., Oren, E., et al. Mepolizumab as a steroid-sparing treatment
option with Churg–Strauss syndrome. J. Allergy Clin. Immunol. 2010; 125:1336-1343.

[47] De Vita, S., Quartuccio, L., Isola, M., et al. A randomized controlled trial of rituximab
for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum. 2012; 64:843-
853.

[48] Sneller, M. C., Hu, Z., Langford, C. A. A randomized controlled trial of rituximab
following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic
vasculitis. Arthritis Rheum. 2012; 64:835-842.

[49] Ferri, C., Cacoub, P., Mazzaro, C., et al. Treatment with rituximab in patients with
mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of
the literature. Autoimmune Rev. 2011; 11:48-55.

[50] Guillevin, L., Cohen, P., Mahr, A., et al. Treatment of polyarteritis and microscopic
polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids
and six or twelve cyclophosphamide pulses in sixty-five patients. Arthritis Rheum.
2003; 49:93-100.

[51] Gayraud, M., Guillevin, L., Cohen, P., et al. Treatment of good-prognosis polyarteritis
nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse
cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides. Br.
J. Rheumatol. 1997; 36:1290-1297.

[52] Guillevin, L., Jarrousee, B., Lok, C., et al. Longterm followup after treatment of
polyarteritis and Churg-Strauss angiitis with comparison of steroids, plasma exchange
and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial
of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa. J. Rheumatol.
1991; 18:567-574.

[53] Guillevin, L., Lhote, F., Leon, A., et al. Treatment of polyarteritis nodosa related to
hepatitis B virus with short term steroid therapy associated with antiviral agents and
plasma exchanges. A prospective trial in 33 patients. J. Rheumatol. 1993; 20:289-298.

[54] Guillevin, L., Mahr, A., Cohen, P., et al. Short-term corticosteroids then lamivudine and
plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis
Rheum. 2004; 51:482-487.

Complimentary Contributor Copy